SNOW rides on surging AI demand, hitting a $100M AI run rate early as AI drives half of bookings and fuels rapid platform adoption.
Earlier this week, CRISPR Therapeutics reported encouraging early-stage clinical data for its allogeneic CD19 CAR T therapy, zugo-cel, in aggressive B-cell lymphoma and autoimmune diseases, and ...
In recent days, Strategy Inc. paused its aggressive Bitcoin purchases and instead raised about US$748 million via common stock sales, lifting its U.S. dollar reserve to roughly US$2.19 billion to ...
Software startup Poolside AI may not be on the radar of most investors in Palantir stock but Poolside looms as a long-term ...
The Mustang Bullitt name has only appeared on a handful of factory cars, but those limited runs have turned into one of the ...
A Decatur couple started hanging large, lighted spheres high up in trees several Christmases ago. This year more than 250 ...
Snowflake Inc. is rated a Strong Buy due to strong revenue growth and high free cash flow margins. Learn more about SNOW ...
Investing.com -- Snowflake (NYSE:SNOW) has earned an Outperform rating from brokerage firm Raymond James, which argues that the stock’s trajectory will hinge on how a set of core strategic and ...